ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,436, issued on April 21, was assigned to Valneva SE (Nantes, France).
"Chikungunya vaccine formulations" was invented by Christoph Reinisch (Siegenfeld, Austria), Robert Schlegl (Siegenfeld, Austria) and Jurgen Heindl-Wruss (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to novel liquid and lyophilized formulations of Chikungunya virus useful as vaccines and methods for their preparation."
The patent was filed on Aug. 10, 2020, under Application No. 17/632,943.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...